Fulcrum Therapeutics (FULC) Asset Utilization Ratio (2020 - 2025)

Fulcrum Therapeutics (FULC) has 6 years of Asset Utilization Ratio data on file, last reported at 0.34 in Q2 2025.

• Asset Utilization Ratio for Q2 2025 came in at 0.34, up 9.51% year-over-year; the trailing twelve-month figure through Jun 2025 was 0.34 (up 9.51% YoY), and the FY2024 annual result was 0.31, up 2564.82% from the prior year.
• Asset Utilization Ratio climbed to 0.34 in Q2 2025 per FULC's latest filing, from 0.3 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.34 in Q2 2025 and troughed at 0.01 in Q3 2023.
• A 5-year average of 0.11 and a median of 0.07 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio tumbled 85.94% in 2023, then surged 3064.27% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.08 in 2021, then tumbled by 65.79% to 0.03 in 2022, then plunged by 60.89% to 0.01 in 2023, then soared by 2735.39% to 0.3 in 2024, then rose by 14.47% to 0.34 in 2025.
• Business Quant data shows FULC's Asset Utilization Ratio at 0.34 in Q2 2025, 0.3 in Q4 2024, and 0.28 in Q3 2024.